A Phase 1 Randomized, Placebo-Controlled, Blinded, Multiple Ascending Dose Study to Evaluate VIB 7734 in Systemic Lupus Erythematosus, Cutaneous Lupus Erythematosus, Sjogren¿s

Administered By

Awarded By

Contributors

Start/End

  • July 16, 2019 - May 11, 2021